Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine

The coronavirus disease 2019 (COVID-19) pandemic has been a serious healthcare problem worldwide since December 2019. The third dose of heterologous vaccine was recently approved by World Health Organization. The present study compared the reactogenicity and immunogenicity of the reduced and standar...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanokudom, Sitthichai, Assawakosri, Suvichada, Suntronwong, Nungruthai, Chansaenroj, Jira, Auphimai, Chompoonut, Nilyanimit, Pornjarim, Vichaiwattana, Preeyaporn, Thongmee, Thanunrat, Yorsaeng, Ritthideach, Duangchinda, Thaneeya, Chantima, Warangkana, Pakchotanon, Pattarakul, Srimuan, Donchida, Thatsanatorn, Thaksaporn, Klinfueng, Sirapa, Mongkolsapaya, Juthathip, Sudhinaraset, Natthinee, Wanlapakorn, Nasamon, Honsawek, Sittisak, Poovorawan, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393164/
https://www.ncbi.nlm.nih.gov/pubmed/36031500
http://dx.doi.org/10.1016/j.vaccine.2022.08.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393164/
https://www.ncbi.nlm.nih.gov/pubmed/36031500
http://dx.doi.org/10.1016/j.vaccine.2022.08.033

Ejemplares similares